vimarsana.com
Home
Live Updates
Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS) : vimarsana.com
Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
EQS-News: Newron Pharmaceuticals S.p.A.
/ Key word: Conference/Study results
Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and... | May 15, 2023
Related Keywords
United States ,
Israel ,
Japan ,
Bresso ,
Lombardia ,
Italy ,
South Korea ,
Seika ,
Kyongsang Bukto ,
India ,
Canada ,
Montreal ,
Quebec ,
Germany ,
Sri Lanka ,
United Kingdom ,
Switzerland ,
Milan ,
United Arab Emirates ,
Australia ,
Toronto ,
Ontario ,
Swiss ,
America ,
Paul Sagan ,
Valentin Handschin ,
Anne Hennecke Caroline Bergmann ,
Stefan Weber ,
Ravi Anand ,
Mc Services ,
Newron Pharmaceuticals ,
Schizophrenia International Research Society ,
Swiss Exchange ,
World Congress ,
European Union ,
Supernus Pharmaceuticals ,
Negative Syndrome Scale ,
Clinical Global Impression ,
Strauss Carpenter Levels ,
Chief Medical Officer ,
Strauss Carpenter Level ,
Latin America ,
Meiji Seika ,
Ciara Martin ,
Natalie Garland Collins ,
Caroline Bergmann ,
Newron Pharmaceuticalss Pa Stock Exchange ,
News ,
Information ,
Press Release ,
Onewron ,
Pharmaceuticals ,
Key ,
Presents ,
Exciting ,
Few ,
Data ,
Rom ,
Study ,
It ,
Vinp ,
World ,
Congress ,
F ,
Europsychopharmacology Nwrn It0004147952 ,
vimarsana.com © 2020. All Rights Reserved.